Is there evidence of adverse effects associated with creatinine supplementation?

Creatine Supplementation Safety Profile

Creatine supplementation does not cause kidney harm in healthy individuals or those with chronic kidney disease, though it increases serum creatinine levels through metabolic turnover rather than actual kidney injury. 1, 2

Key Evidence on Renal Safety

The most recent and comprehensive meta-analyses from 2025-2026 definitively demonstrate that creatine supplementation:

• Increases serum creatinine by 0.07-0.14 mg/dL - a modest elevation reflecting increased creatine metabolism, not kidney damage 1, 2
• Does not alter true GFR when measured by gold-standard Cr-EDTA clearance (MD 5.89 mL/min, p=0.06) 1
• Falsely lowers creatinine-based GFR estimates (MD -10.75 mL/min) because the equations misinterpret elevated creatinine as kidney dysfunction 1
• Does not increase serum urea, albuminuria, or proteinuria 1

This creates a critical clinical pitfall: creatinine-based GFR calculations will incorrectly suggest kidney injury in patients taking creatine. In one case study, a patient with a solitary kidney taking 20g/day creatine showed rising serum creatinine (1.03→1.27 mg/dL) but unchanged true GFR by isotope clearance 3.

Adverse Effects Profile

Analysis of 685 clinical trials involving 12,839 participants taking creatine revealed 4:

• No difference in total adverse events between creatine (13.7% of studies) and placebo (13.2% of studies, p=0.776)
• Gastrointestinal issues occurred in 4.9% of creatine studies vs 4.3% placebo studies (p<0.001 for studies, but p=0.820 when analyzing total participants)
• Muscle cramping/pain reported in 2.9% of creatine studies vs 0.9% placebo (p=0.008), but only 0.52% vs 0.07% of participants (p=0.085)
• No deaths or serious adverse events in female-only studies (951 participants) 5

Long-term supplementation (average 310 days, up to 14 years in some studies) showed 6:

• No increase in plasma urea levels
• No increase in microalbuminuria prevalence (5.4%→1.8%)
• Occasional water retention/edema
• Rare severe GI symptoms (3/175 participants discontinued)

Special Populations

Living Kidney Donors

The 2020 American Journal of Kidney Diseases guideline specifically addresses creatine in kidney donors 3:

• Creatine can cause rhabdomyolysis (mechanism listed alongside other nephrotoxic supplements)
• Interferes with accurate GFR assessment during donor evaluation
• Recommendation: Discourage all dietary supplements in kidney donor candidates to avoid masking kidney dysfunction or compromising surgical outcomes
• The guideline emphasizes that supplements should not influence GFR estimation postdonation

Hemodialysis Patients

In hemodialysis subgroup analysis 1:

• Creatine increased serum creatinine (expected)
• Significantly reduced serum urea levels (potentially beneficial)

Athletes and Body Composition

Sports medicine guidelines from 2025 7:

• 12 papers recommend creatine for increasing body/fat-free mass
• Typical dosing: 15-20 g/day loading (4 divided doses) for 5-7 days, then 1-5 g/day maintenance
• Only 2 pre-2004 papers advised against use due to insufficient evidence (now outdated)

Clinical Implications

For healthy individuals and athletes: Creatine supplementation is safe with typical dosing (3-5 g/day maintenance, 15-20 g/day loading). The primary concern is misinterpretation of elevated serum creatinine as kidney disease 1, 4, 2.

For CKD patients: Emerging evidence suggests creatine may be beneficial for sarcopenia, frailty, and cognitive impairment in CKD, with no evidence of harm 8. However, creatinine-based GFR monitoring becomes unreliable.

For kidney donor candidates: Avoid creatine during evaluation and perioperatively due to interference with GFR assessment and theoretical rhabdomyolysis risk, despite lack of direct nephrotoxicity evidence 3.

For monitoring: Use cystatin C-based GFR estimates or measured GFR (iothalamate, Cr-EDTA) rather than creatinine-based equations in patients taking creatine 3, 1.

Dosing Context

Adequate dietary intake for maintenance is minimal: 5.4 mg/kg/day for men (400 mg/day) and 4.1 mg/kg/day for women (240 mg/day) 9. Supplementation doses (3-5 g/day) far exceed dietary requirements, explaining the metabolic effects on creatinine levels.